A phase II study of fixed dose rate gemcitabine in patients with relapsed müllerian tumors.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/05FDEF1F.svg?ark=w1%2F20260515%2F05FDEF1F)](https://nobleid.org/work/w1/20260515/05FDEF1F)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors